SCHEMBL8856482

SCHEMBL8856482

NC(=O)C(=O)NN=c1c(=O)c2ccccc2c1=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.60
SMN1; SMN2 Q16637 5/20 0.60
SENP6 Q9GZR1 3/20 0.60
KMT2A Q03164 3/20 0.60
ALDH1A1 P00352 3/20 0.60
CASP3 P42574 2/20 0.60
SENP8 Q96LD8 2/20 0.60
SENP7 Q9BQF6 2/20 0.60
APAF1 O14727 1/20 0.60
TDP2 O95551 1/20 0.60
CYP1A2 P05177 1/20 0.60
CYP2D6 P10635 1/20 0.60
THRB P10828 1/20 0.60
CYP2C9 P11712 1/20 0.60
CYP2C19 P33261 1/20 0.60
HTT P42858 3/20 0.47
KDM4E B2RXH2 7/20 0.44
NPC1 O15118 4/20 0.44
RAB9A P51151 3/20 0.44
MEN1 O00255 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9004597 0.85 MAPT (0.64) MAPTSMN1; SMN2SENP6KMT2AALDH1A1
SCHEMBL8856519 0.75 SENP6 (0.61) MAPTSMN1; SMN2SENP6KMT2AALDH1A1
SCHEMBL8856654 0.75 ALDH1A1 (1.00) MAPTSMN1; SMN2SENP6KMT2AALDH1A1
SCHEMBL8856632 0.73 KMT2A (0.77) MAPTSMN1; SMN2SENP6KMT2AALDH1A1
SCHEMBL8667830 0.72 SENP6 (0.61) MAPTSMN1; SMN2SENP6KMT2AALDH1A1
SCHEMBL8602196 0.72 MAPT (0.57) MAPTSMN1; SMN2SENP6KMT2AALDH1A1
SCHEMBL9227706 0.71 MAPT (0.51) MAPTSMN1; SMN2SENP6KMT2AALDH1A1
SCHEMBL9232385 0.71 SENP6 (0.51) MAPTSMN1; SMN2SENP6KMT2AALDH1A1
SCHEMBL8856609 0.71 SMN1; SMN2 (0.79) MAPTSMN1; SMN2SENP6KMT2AALDH1A1
SCHEMBL9004614 0.71 MAPT (0.59) MAPTSMN1; SMN2SENP6KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5648381-A Derivatives of indan-1,3-dione and indan-1,2,3-trione, methods of preparing them and therapeutic use thereof INNOTHERA (FR) 1997-07-15 US disclosed
EP-0566446-B1 Derivatives of indane-1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy INNOTHERA LAB SA (FR) 1996-02-07 EP disclosed
EP-0566446-A1 Derivatives of indane-1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy INNOTHERA (FR) 1993-10-20 EP disclosed
WO-1993020046-A1 INDAN-1,3-DIONE AND INDAN-1,2,3-TRIONE DERIVATIVES, PROCESSES FOR PREPARATION OF SAME AND THEIR USE AS THERAPEUTIC AGENTS INNOTHERA (FR) 1993-10-14 WO disclosed